Article By:
BioMedReports
Friday, October 24, 2014 4:27 AM EDT
SBOTF and BTVI announced the companies have executed a definitive supply agreement to meet Biovest's requirements for Keyhole Limpet Hemocyanin for use in Biovest's BiovaxID® active immunotherapy